
Keywords: 16; 23; 38; ADP; adenosine diphosphate; APT; antiplatelet therapy; BOCLA-Plan; BOchum CLopidogrel and Aspirin Plan; CABG; coronary artery bypass grafting; CI; confidence interval; CYP; cytochrome P450; dAPT; dual antiplatelet therapy; HR; hazard ratio; hR